Besides, the densities of Ki67+ CD8+, Granzyme-B+ CD8+, and CD107a+ CD8+ T cells were markedly upregulated in the combination therapy group, indicating the higher tumor-killing capability (Fig. 6b–6d). Here, MKI67 is linked to neoplasm.